investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide

Dennis Klinman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Eric B. Haura

AN ACTIVE ROLE OF ADAPTOR PROTEINS IN TYROSINE KINASE INHIBITOR RESISTANCE

Trachea, bronchus and lung

Investigator from Max Delbrück Center for Molecular Medicine (HZ)

Enzymatic DNA deamination and the immunity/cancer balance

All cancers but non-melanoma skin cancer

David L Woodland

Tumor Metabolism

All cancers but non-melanoma skin cancer

Augustin Luna

Chemogenomic Analysis of the NCI Therapeutic Compound Database

All cancers but non-melanoma skin cancer

Binghui Shen

Dynamic Functions of DNA2 Counteract DNA Replication Stresses and Tumorigenesis

All cancers but non-melanoma skin cancer

Radiation Oncology

David J. Kwiatkowski

Molecular Pathogenesis of the Hamartoma Syndromes

All cancers but non-melanoma skin cancer

Pathology

Ramasamy Paulmurugan

Molecular Sensors for Imaging Histone Methylations in Living Animals

All cancers but non-melanoma skin cancer

Tudor Oprea

Illuminating the Druggable Genome

All cancers but non-melanoma skin cancer

Andrew B Lawson

Uncertainty in Spatial Health Analysis Due to Missingness and Aggregation Effects

All cancers but non-melanoma skin cancer